Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Karuna Therapeutics (KRTX) Insider Trading & Ownership

Karuna Therapeutics (NASDAQ:KRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$11.70 M
Get KRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karuna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KRTX Insider Buying and Selling by Quarter

Karuna Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/8/2024Stephen K BrannanInsiderSell5,000$318.34$1,591,700.00  
2/8/2024Stephen K BrannanInsiderSell5,000$316.13$1,580,650.00  
1/8/2024Stephen K BrannanInsiderSell15,000$316.81$4,752,150.00  
12/8/2023Stephen K BrannanInsiderSell10,000$202.37$2,023,700.00  
11/8/2023Stephen K BrannanInsiderSell5,000$177.85$889,250.00  
10/9/2023Stephen K BrannanInsiderSell5,000$173.24$866,200.00  
(Data available from 1/1/2013 forward)

KRTX Insider Trading Activity - Frequently Asked Questions

13.20% of Karuna Therapeutics stock is owned by insiders. Learn more on KRTX's insider holdings.

The following insiders have sold KRTX shares in the last 24 months: Andrew Craig Miller ($15,807,450.00), James Healy ($1,204,797.30), Jeffrey M Jonas ($5,299,261.47), Laurie J Olson ($215,650.00), Stephen K Brannan ($19,526,600.00), and Troy A Ignelzi ($9,390,791.00).

Insiders have sold a total of 238,446 Karuna Therapeutics shares in the last 24 months for a total of $51,831,199.77 sold.



This page (NASDAQ:KRTX) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners